Intuitive Surgical (ISRG) April 375 straddle priced into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
- ServiceNow (NOW) Misses Q3 EPS by 2c, Beats on Revenue; Offers Q4 Revenue Guidance
- Oracle sets $225 billion revenue target for FY30 at investor day
- Amazon (AMZN) Misses Q3 EPS by 7c, Misses on Revenue; Offers Q4 Revenue Guidance
- Rivian shares slip ahead of Thursday earnings release
- Marvell in advanced talks to acquire Lumentum, Bloomberg reports
Intuitive Surgical (ISRG) PT Raised to $375 at Jefferies
April 19, 2024 7:55 AM EDTJefferies analyst Matthew Taylor raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $375.00 (from $365.00) while maintaining a Hold rating.
The analyst comments "ISRG reported 1Q24 revs of $1.89B +11% vs cons $1.87B and EPS of $1.50 +22%, above cons. $1.42. Procedures grew 16% on a tough comp, 'good... More
Intuitive Surgical (ISRG) PT Raised to $390 at Deutsche Bank
April 19, 2024 5:17 AM EDTDeutsche Bank analyst Imron Zafar raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $390.00 (from $370.00) while maintaining a Hold rating.
The analyst comments "Net/net, 1Q results clearly evidenced that robotic surgery market fundamentals remain quite robust, and our bullish... More
Intuitive Surgical (ISRG) PT Raised to $421 at BTIG
April 19, 2024 5:13 AM EDTBTIG analyst Ryan Zimmerman raised the price target on Intuitive Surgical (NASDAQ: ISRG) to $421.00 (from $412.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $421 (from $412) following 1Q24 results. ISRG reported revenue of $1.89B (+11.5% Y/Y) and adj. EPS of $1.50 vs. BTIG/Cons.... More



